Skip to main content
Erschienen in: BMC Infectious Diseases 1/2006

Open Access 01.12.2006 | Research article

Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries

verfasst von: Paul K Drain, Daniel T Halperin, James P Hughes, Jeffrey D Klausner, Robert C Bailey

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2006

Abstract

Background

Both religious practices and male circumcision (MC) have been associated with HIV and other sexually-transmitted infectious diseases. Most studies have been limited in size and have not adequately controlled for religion, so these relationships remain unclear.

Methods

We evaluated relationships between MC prevalence, Muslim and Christian religion, and 7 infectious diseases using country-specific data among 118 developing countries. We used multivariate linear regression to describe associations between MC and cervical cancer incidence, and between MC and HIV prevalence among countries with primarily sexual HIV transmission.

Results

Fifty-three, 14, and 51 developing countries had a high (>80%), intermediate (20–80%), and low (<20%) MC prevalence, respectively. In univariate analyses, MC was associated with lower HIV prevalence and lower cervical cancer incidence, but not with HSV-2, syphilis, nor, as expected, with Hepatitis C, tuberculosis, or malaria. In multivariate analysis after stratifying the countries by religious groups, each categorical increase of MC prevalence was associated with a 3.65/100,000 women (95% CI 0.54-6.76, p = 0.02) decrease in annual cervical cancer incidence, and a 1.84-fold (95% CI 1.36-2.48, p < 0.001) decrease in the adult HIV prevalence among sub-Saharan African countries. In separate multivariate analyses among non-sub-Saharan African countries controlling for religion, higher MC prevalence was associated with a 8.94-fold (95% CI 4.30-18.60) decrease in the adult HIV prevalence among countries with primarily heterosexual HIV transmission, but not, as expected, among countries with primarily homosexual or injection drug use HIV transmission (p = 0.35).

Conclusion

Male circumcision was significantly associated with lower cervical cancer incidence and lower HIV prevalence in sub-Saharan Africa, independent of Muslim and Christian religion. As predicted, male circumcision was also strongly associated with lower HIV prevalence among countries with primarily heterosexual HIV transmission, but not among countries with primarily homosexual or injection drug use HIV transmission. These findings strengthen the reported biological link between MC and some sexually transmitted infectious diseases, including HIV and cervical cancer.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2334-6-172) contains supplementary material, which is available to authorized users.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

PKD, DTH, JPH, and RCB designed the study. PKD, DTH, and RCB collected and analyzed data. PKD, DTH, JPH, JDK, and RCB interpreted the results. PKD primarily wrote the manuscript. DTH, JPH, JDK, and RCB provided valuable insight for revising the manuscript. All authors read and approved the final manuscript.
Abkürzungen
HIV
human immunodeficiency virus
HSV-2
herpes simplex virus type-2
STIs
sexually-transmitted infections
UNDP
United Nations Development Programme
UNAIDS
The Joint United Nations Programme on HIV/AIDS
HPV
human papillomavirus

Background

Geographical variations in HIV prevalence have been observed between less-developed and more-developed countries, as well as within regions of similar socioeconomic development [15]. The epidemiology of HIV and other infectious diseases have been associated with both religious practices and male circumcision [119]. Religious beliefs and practices dictate many societal and sexual behaviors that influence transmission of sexually-transmitted infections (STIs) [20]. Male circumcision has been more common among populations with lower rates of HIV, cervical cancer, and other STIs [3, 1013], and shown in one randomized trial to reduce HIV transmission [21]. Although religious affiliation is a major determinant of male circumcision status [12], many analyses have not controlled for religion when examining relationships between male circumcision and infectious diseases.
This study builds upon and further expands our previously reported analyses of variables associated with country-specific HIV prevalence and cervical cancer incidence [5, 22]. In our extensive analysis of HIV co-factors, among 81 variables male circumcision had the strongest association with HIV prevalence [5]. We now present a more thorough examination of the association between male circumcision and HIV prevalence by better adjusting for religion, by separately analyzing the sub-Saharan African region, and by conducting separate analyses between countries with sexual versus non-sexual primary modes of HIV transmission. Our previous ecological analysis of cervical cancer utilized 54 country-level variables, but did not include the important determinant of male circumcision [13, 22]. We complete our previous analysis by describing the relationships between male circumcision and cervical cancer, and by including male circumcision in the previously reported multivariate model. In addition, we further expand on our previous studies by describing the epidemiology of male circumcision among developing countries and by describing associations between male circumcision and five other infectious diseases.

Methods

We conducted an ecological study of country-level variables among developing countries. The United Nations Development Programme (UNDP) 'Human Development Report 2004' provided the Human Development Index, which determines each country's development status on the basis of life expectancy, educational attainment, and adjusted real income [23]. Countries classified as high human development ("developed") countries were excluded from the analyses under the assumption that they have greater capacity to sustain national treatment and prevention programs, and have different epidemiological infectious disease profiles. Therefore, subsequent country-specific data were collected for 122 low and medium human development ("developing") countries.

Data collection

The Joint United Nations Programme on HIV/AIDS (UNAIDS) provided country-specific age-standardized HIV seroprevalence per 100 adults 15–49 years old for the year 2004 for 100 countries [24]. Countries with <0.1% of adults infected with HIV were considered to have an adult seroprevalence of 0.05%. The International Agency for Research on Cancer provided country-specific annual age-standardized cervical cancer incidence [a surrogate measure for Human Papillomavirus (HPV)] per 100,000 females for the year 2000 for 117 countries and the most recent country-specific Herpes Simplex Virus type-2 (HSV-2) seroprevalence per 100 women for 23 countries [25, 26]. The World Health Organization provided the most recent country-specific syphilis seroprevalence per 10,000 women for 43 countries [27], and Hepatitis C prevalence per 100 adults for 75 countries [28]. The UNDP provided country-specific prevalence of all forms of tuberculosis per 100,000 people for the year 2002 for 110 countries and malaria prevalence per 10,000 people for the year 2000 for 94 countries [23]. We did not include chlamydia or gonorrhea in this analysis due to a lack of available data.
We used survey data from various published sources [3, 1113, 15, 29, 30], including Demographic and Health Surveys and Behavioral Surveillance Surveys [3135] to categorize the country-wide prevalence of male circumcision as "low" (<20%), "intermediate" (20–80%), or "high" (>80%), as we have previously done [5, 10]. These categories were chosen to best minimize misclassification. When published country-specific data were not available, we used ethnographic confidence methods, as previously utilized by Halperin and Bailey [5, 10], to categorize country-specific male circumcision prevalence as low, intermediate, or high. The classification of country-specific male circumcision prevalence was independently verified by three colleagues (listed in Acknowledgements). We omitted four developing countries (Armenia, Belarus, Kyrgyzstan, and Vanuatu) from all analyses because their male circumcision prevalence could not be confidently categorized.
The United Nations Population Division provided all population statistics estimated for the year 2000 [36]. UNAIDS provided data for geographical regions [24]. We used the first listed mode of transmission from the UNAIDS 'HIV/AIDS Epidemic Update 2002' as the primary mode of HIV transmission for each geographical region [37]. The United States Central Intelligence Agency 'The World Factbook' provided both the percentage of Muslims and the percentage of Christians within each country [38].

Statistical analyses

Statistical analyses were conducted on 118 developing countries using Stata Version 8.0 [39]. All regression statistics were performed using a robust variance to account for unmeasured ecologic and population differences. We conducted separate analyses of HIV prevalence among sub-Saharan African and non-sub-Saharan African countries due to the differing severity and nature of the epidemics [4042]. We also conducted separate analyses among non-sub-Saharan African regions whose primary mode of HIV transmission was heterosexual contact versus homosexual contact or injection drug use [24]. Heterosexual contact was the primary mode of HIV transmission for the sub-Saharan African region. HIV seroprevalence was natural log (ln)-transformed to create a more normal distribution for regression analyses. Countries were categorized into tertiles as having low (<5%), intermediate (5–55%), and high (>55%) percentage of predominantly Muslims, and as having low (<6%), intermediate (6–55%), and high (>55%) percentage of predominantly Christians.
The mean and standard deviation for each infectious disease were separately summarized among countries with low and high male circumcision prevalence. Means and standard deviations for cervical cancer incidence and HIV prevalence were also separately summarized among countries with low and high male circumcision prevalence within each religious tertile group. Means and standard deviations were analyzed for statistical significance between high versus low male circumcision groups using 2-sample t tests for independent samples with unequal variances.
Univariate linear regression statistics examined category of male circumcision prevalence with each infectious disease. Results are presented by order of the R 2 value, which estimates the amount of the variance explained by the association. Since only HIV prevalence and cervical cancer incidence were significantly associated with male circumcision in univariate analyses, subsequent multivariate analyses were only performed for these two outcomes. Multivariate analyses of covariance models included each country's percentage of the population Muslim and percentage of the population Christian.
Additional multivariate analyses were conducted for cervical cancer incidence and HIV prevalence based on our previously published models [5, 22]. In brief, a multivariate model of cervical cancer incidence was conducted adjusting for the 6 additional variables that were previously found to be significant (p < 0.05) indicators of cervical cancer incidence. Definitions and sources of these variables (number of doctors per 100,000 people, percent of children immunized for measles, female disability-adjusted life expectancy in years, percent of female adult illiteracy rate, percent of infants with low birth weight, and geographic region as defined by the International Agency for Research on Cancer), have been previously described [22]. Similarly, a multivariate model of HIV prevalence was conducted adjusting for the 6 additional variables that were previously found to be significant (p < 0.05) indicators of HIV prevalence. Detailed methods, including definitions and sources of these variables (years since HIV was first reported, geographic region, percent of the population younger than 25 years, percent of female adult illiteracy rate, percent of children fully immunized for diphtheria, tetanus, and pertussis, and number of doctors per 100,000 people), have been previously described [5].

Results

Male circumcision prevalence

The classification of male circumcision prevalence is listed in Table 1 for 118 developing countries. Among these, 53 countries, containing 700 million males, were categorized as having a high (>80%) male circumcision prevalence, 14 countries, containing 135 million males, were categorized as having an intermediate (20–80%) male circumcision prevalence, and 51 countries, containing 1.6 billion males, were categorized as having a low (<20%) male circumcision prevalence.
Table 1
Category of male circumcision prevalence for 118 developing countries.
Male Circumcision Prevalence
Low (<20%)
Intermediate (20–80%)
High (>80%)
Belize
Micronesia, Fed States
Albania
Afghanistan
Liberia
Bhutan
Moldova, Rep of
Bosnia Herzegovina
Algeria
Libyan Arab Jama
Bolivia
Mongolia
Central African Republic
Angola
Madagascar
Botswana
Myanmar
Cote d'Ivoire
Azerbaijan
Malaysia
Brazil
Namibia
Ethiopia
Bangladesh
Maldives
Bulgaria
Nepal
Kazakhstan
Benin
Mali
Burundi
Nicaragua
Lesotho
Burkina Faso
Mauritania
Cambodia
Panama
Macedonia, FYR of
Cameroon
Mauritius
Cape Verde
Papua New Guinea
Mozambique
Chad
Morocco
China
Paraguay
South Africa
Comoros
Niger
Colombia
Peru
Sudan
Congo (Brazzaville)
Nigeria
Dominican Republic
Romania
Tanzania, United Rep of
Dem Rep of the Congo
Oman
Ecuador
Russian Federation
Uganda
Djibouti
Pakistan
El Salvador
Rwanda
Yugoslavia
Egypt
Philippines
Fiji
Samoa
 
Equatorial Guinea
Saudi Arabia
French Polynesia
Solomon Islands
 
Eritrea
Senegal
Georgia
Sri Lanka
 
Gabon
Sierra Leone
Guatemala
Suriname
 
Gambia
Somalia
Guyana
Swaziland
 
Ghana
Syrian Arab Rep
Haiti
Thailand
 
Guinea
Tajikistan
Honduras
Ukraine
 
Guinea-Bissau
Togo
India
Venezuela
 
Indonesia
Tunisia
Jamaica
Viet Nam
 
Iran, Islam Rep of
Turkey
Korea, DPR
Zambia
 
Iraq
Turkmenistan
Lao, PDR
Zimbabwe
 
Jordan
Uzbekistan
Malawi
  
Kenya
Yemen
   
Lebanon
 
Male circumcision prevalence had a distinct geographical pattern. Thirteen of 14 (93%) developing countries in North Africa and the Middle East had a high male circumcision prevalence. Twenty-eight of 45 (62%) sub-Saharan African countries had a high male circumcision prevalence. Eight of 27 (30%) Southeast Asian and Pacific Island countries had a high male circumcision prevalence, and most circumcised males resided in Indonesia, Pakistan, Bangladesh, or the Philippines. Only 4 of 18 (22%) developing countries in Europe and Central Asia had a high male circumcision prevalence, and all 18 developing countries in Latin American and the Caribbean region had a low male circumcision prevalence.

Male circumcision and religion

As expected, male circumcision was strongly associated with religious variables (data not presented). A greater percent of the population being Muslim was strongly associated with more male circumcision prevalence (p < 0.001). Conversely, a greater percent of the population being Christian was strongly associated with less male circumcision (p < 0.001). Among 49 countries with high male circumcision prevalence, the mean percentage of the population Muslim was 69% and the mean percentage of the population Christian was 16%.

Male circumcision and infectious diseases

In univariate regression analyses, male circumcision was associated with HIV prevalence among sub-Saharan African countries, HIV prevalence among non-sub-Saharan African countries with primarily heterosexual contact, HIV prevalence among non-sub-Saharan countries with primarily homosexual contact or injection drug use, and cervical cancer incidence (Table 2). Male circumcision was not associated with HSV-2, syphilis, nor, as expected, with the non-sexually-transmitted-disease prevalences of Hepatitis C, tuberculosis, or malaria. Among sub-Saharan African countries, HIV prevalence was 3.0% among countries with a high male circumcision prevalence and 16.5% among countries with a low male circumcision prevalence (p < 0.001). Among non-sub-Saharan African countries with primarily heterosexual HIV transmission, HIV prevalence was 0.09% among countries with a high male circumcision prevalence and 0.76% among countries with a low male circumcision prevalence (p < 0.001). Similarly, the mean annual cervical cancer incidence was 20.5/100,000 women among countries with a high male circumcision prevalence and 35.0/100,000 women among countries with a low male circumcision prevalence (p < 0.001). Although there was no significant association between male circumcision and HSV-2 prevalence, the size and direction of the coefficient suggests that male circumcision could be associated with reduced HSV-2 prevalence given a larger sample size.
Table 2
Male circumcision prevalence and selected infectious diseases among developing countries.
 
Univariate linear regression of male circumcision prevalence1
Countries with low (<20%) male circumcision prevalence
Countries with high (>80%) male circumcision prevalence
 
No. of countries
Regression coefficient
R 2*
No. of countries
Mean ± SD*
No. of countries
Mean ± SD*
HIV prevalence among sub-Saharan Africa (/100 adults)2
38
-0.90
0.51
8
16.48 ± 0.002
22
2.98 ± 0.002
HIV prevalence among non-sub-Saharan African countries with primarily heterosexual HIV transmission (/100 adults)2
29
-1.08
0.51
11
0.76 ± 0.004
17
0.09 ± 0.002
HIV prevalence among non-sub-Saharan African countries with primarily homosexual or injection drug use HIV transmission (/100 adults)2
33
-1.03
0.29
25
0.41 ± 0.004
4
0.06 ± 0.001
Cervical cancer incidence (/100,000 women/year)
117
-7.2
0.18
51
35.0 ± 16.2
52
20.5 ± 12.8
Herpes Simplex Virus type-2 prevalence (/100 women)
23
-6.1
0.08
10
42.9 ± 13.8
9
30.2 ± 21.6
Tuberculosis prevalence (/100,000)
110
25.9
0.01
48
244 ± 191
49
296 ± 244
Hepatitis C prevalence (/100 adults)
75
0.20
0.003
37
3.17 ± 3.90
34
3.46 ± 3.81
Syphilis prevalence (/10,000 women)
43
51.7
0.0006
20
295 ± 235
14
284 ± 317
Malaria prevalence (/10,000)
94
-31.7
0.0007
31
385 ± 887
31
331 ± 596
SD – standard deviation.
* R2 values and mean values in bold type had p-values <0.001 and in italics type had p-values <0.05. R2 values and mean values not in bold or italics type had p-values >0.05.
1 Male circumcision prevalence was coded as 1 = low (<20%), 2 = intermediate (20–80%), and 3 = high (>80%).
2 Regression analyses presented as natural log of HIV (prevalence/100,000 adults).

Religion and infectious diseases

In univariate regression analyses, religion was also strongly associated with HIV and cervical cancer. Each percent increase of the population Muslim was associated with a 0.21/100,000 women (CI 0.15-0.28, p < 0.001) decrease in cervical cancer incidence, and a 1.25-fold (CI 1.16-1.35, p < 0.001) and 1.19-fold (CI 1.12-1.27, p < 0.001) decrease in adult HIV prevalence among sub-Saharan African and non-sub-Saharan African countries, respectively. Similarly, each percent increase of the population Christian was associated with a 0.26/100,000 women (CI 0.19-0.34, p < 0.001) increase in cervical cancer incidence, and a 1.32-fold (CI 1.20-1.45, p < 0.001) and 1.20-fold (CI 1.12-1.30, p < 0.001) increase in adult HIV prevalence among sub-Saharan African and non-sub-Saharan African countries, respectively.

Male circumcision, religion, and infectious diseases

Mean rates of cervical cancer incidence and HIV prevalence are presented among countries with low and high male circumcision prevalence in Figures 1, 2, 3, after separately stratifying countries into tertiles for percent Muslim and percent Christian. In nearly all religious tertile groups, mean cervical cancer incidence or HIV prevalence was lower among countries with a high male circumcision prevalence. Mean differences between high and low male circumcision groups were statistically significant for 7 of 14 (50%) tertile groups, and 2 additional tertile groups (14%) showed a borderline significance. When excluding each of the major religions in separate multivariate analyses, there were no meaningful changes in the associations between infectious diseases and male circumcision prevalence.
In a multivariate model, percent of the population Christian and male circumcision, but not percent of the population Muslim, remained independently associated with cervical cancer incidence (Table 3). After stratifying the countries by religious groups, each categorical increase of male circumcision prevalence was associated with a 3.65/100,000 women (CI 0.54-6.76, p = 0.02) decrease in annual cervical cancer incidence. These 3 measures (prevalence of male circumcision, percent Muslim, and percent Christian) accounted for 40% of the variance in cervical cancer incidence among the 105 developing countries included in the model. In a multivariate model adjusted for 6 additional country-specific variables previously found to be associated with cervical cancer incidence [22], each categorical increase of male circumcision prevalence was highly associated with a 10.38/100,000 women (CI 4.94-15.82, p < 0.001) decrease in annual cervical cancer incidence. The 9 variables accounted for 59% of the variance in cervical cancer incidence among the 85 countries included in the model. Furthermore, male circumcision had a stronger association with cervical cancer incidence than all the other variables included in the model.
Table 3
Multivariate linear regression models of cervical cancer incidence (/100,000 women/year) among developing countries.
 
No. of countries
coefficient
p-value
R 2
Unadjusted regression model
105
  
0.40
Percent of population Muslim
 
-0.010
0.84
 
Percent of population Christian
 
0.21
<0.001
 
Male circumcision prevalence1
 
-3.65
0.022
 
Adjusted regression model 2
85
  
0.59
Percent of population Muslim
 
0.083
0.25
 
Percent of population Christian
 
0.13
0.017
 
Male circumcision prevalence1
 
-10.38
<0.001
 
1 Male circumcision prevalence was coded as 1 = low (<20%), 2 = intermediate (20–80%), and 3 = high (>80%).
2 Model adjusted by country-specific measures including number of doctors per 100,000 people, percent of children immunized for measles, female disability-adjusted life expectancy in years, percent of female adult illiteracy rate, percent of infants with low birth weight, and major geographic region.
Among sub-Saharan African countries, percent of the population Muslim and male circumcision, but not percent of the population Christian, remained independently associated with HIV prevalence (Table 4). After stratifying the countries by religious groups, each categorical increase of male circumcision prevalence was associated with a 1.84-fold (CI 1.36-2.48, p < 0.001) decrease in adult HIV prevalence. In a multivariate model adjusted for 6 additional country-specific variables previously found to be associated with HIV prevalence [5], each categorical increase of male circumcision prevalence was associated with a 2.27-fold (CI 1.51-3.42, p = 0.001) decrease in adult HIV prevalence.
Table 4
Multivariate linear regression models of HIV prevalence (/100,000 adults) among developing countries.1
 
Sub-Saharan African countries with heterosexual contact as primary mode of HIV transmission
Non-Sub-Saharan African countries with heterosexual contact as primary mode of HIV transmission
Non-Sub-Saharan African countrieswith homosexual contact or injection-drug use as primary mode of HIV transmission
 
No. of countries
Regression coefficient
p-value
R 2
No. of countries
Regression coefficient
p-value
R 2
No. of countries
Regression coefficient
p-value
R 2
Unadjusted regression model
35
  
0.68
24
  
0.70
32
  
0.49
Percent of population Muslim
 
-0.013
0.023
  
0.031
0.02
  
0.021
0.51
 
Percent of population Christian
 
0.0015
0.84
  
0.021
0.04
  
0.017
0.003
 
Male circumcision prevalence2
 
-0.61
<0.001
  
-2.19
<0.001
  
-1.26
0.35
 
Adjusted regression model 3
27
  
0.85
22
  
0.72
23
  
0.73
Percent of population Muslim
 
-0.011
0.026
  
0.014
0.19
  
-0.036
0.26
 
Percent of population Christian
 
-0.0044
0.48
  
0.0011
0.94
  
0.015
0.15
 
Male circumcision prevalence2
 
-0.82
0.001
  
-1.60
0.001
  
0.47
0.70
 
1 Analyses conducted with natural log of HIV seroprevalence.
2 Male circumcision prevalence was coded as 1 = low (<20%), 2 = intermediate (20–80%), and 3 = high (>80%).
3 Model adjusted by country-specific measures including years since HIV was first reported, major geographical region, percent of population younger than age 25, percent of female adult illiteracy rate, percent of children fully immunized for diphtheria, tetanus, and pertussis, and number of doctors per 100,000 people.
Among all non-sub-Saharan African countries, male circumcision remained independently associated with HIV prevalence among countries in regions with heterosexual contact as the primary mode of HIV transmission, but not among countries in regions with either homosexual contact or injection drug use as the primary mode of HIV transmission (Table 4). When stratifying the countries by religious groups among countries with primarily heterosexual HIV transmission, each categorical increase of male circumcision prevalence was associated with a 8.94-fold (95% CI 4.30-18.60) decrease in adult HIV prevalence. In a multivariate model adjusted for 6 additional country-specific variables [5], each categorical increase of male circumcision prevalence was associated with a 4.94-fold (95% CI 2.29-10.65, p = 0.001) decrease in adult HIV prevalence. In a separate multivariate model, after stratifying the countries by religious groups among countries with primarily homosexual contact or injection drug use HIV transmission, male circumcision was not significantly associated with HIV prevalence (p = 0.35). When adjusting the multivariate model for the 6 additional country-specific variables [5], male circumcision prevalence was not significantly associated with HIV prevalence (p = 0.70).

Discussion

This ecological study of 118 developing countries expands results from our previous analyses [5, 22] by elucidating patterns and associations between male circumcision, religion, and infectious diseases, particularly HIV. Male circumcision, which is routinely practiced in the Middle East, northern and western Africa, and western Asia, was associated with lower rates of certain STIs, HIV and cervical cancer (a proxy for HPV), but not with infections transmitted by non-sexual routes. In general, more male circumcision was strongly associated with lower cervical cancer rates and fewer HIV cases, independent of religion. Furthermore, male circumcision was independently associated with HIV among countries with primarily heterosexual HIV transmission, and not among countries with primarily homosexual or injection drug use HIV transmission. These findings all suggest that male circumcision is a true protective factor that reduces the sexual transmission of HIV and possibly HPV, independent of Muslim and Christian religions.
An ecologic study of this type has limitations, as we have previously acknowledged [5, 22]. In brief, ecological analyses cannot measure correlates of risk at the individual-level. Second, the temporal sequence of events in individuals is undetermined. Since the approximate age at circumcision varies by country, the results could be affected if a significant proportion delayed male circumcision until after initiation of sexual activity. Third, the validity of country-level data undoubtedly varies, and some data, such as HSV-2 prevalence, were not available for many countries. Although mean HSV-2 prevalence was lower among countries with more male circumcision, the limited number of countries with HSV-2 data (23 countries) gave relatively low power for examining the significance of this association. Fourth, and perhaps most importantly, statistics on the distribution and variation within countries were not complete. Some countries, such as Kenya, have widely varying regional prevalences of male circumcision and HIV [32]. For example, western Kenya, where less than 20% of males are circumcised, has a much higher HIV prevalence than regions of the country where nearly all men are circumcised [3, 32]. The 2003 Kenya survey also found uncircumcised males had over three-fold higher HIV prevalence as compared to circumcised males, and HIV prevalence in circumcised men was nearly identical among the major religious groups (2.6% among Catholics, 3.0% in Protestant/other Christians, and 2.9% in Muslims) [32]. Finally, not all population-level measures that may impact infectious disease transmission, such as patterns of risk behaviors, condom availability and utilization, and injection drug use, were included in this analysis. Despite these limitations, findings from this ecological analysis support a biological relationship between male circumcision and certain STIs.
Previous studies, including a recent Cochrane review [16], have also found male circumcision to be associated with a reduced risk of HPV detection in men [14], cervical cancer in female partners [13], and HIV infection [3, 11, 12, 15, 17], while associations between male circumcision and HSV-2 and gonorrhea are less clear [15, 19, 43]. However, these studies were generally conducted among geographically-limited populations and many were unable to adequately control for religion. By comparison, our study described the global distribution of male circumcision prevalence, examined a large number of geographically-diverse countries and several infectious diseases, separately analyzed countries by primarily heterosexual and non-heterosexual transmission of HIV, and included relatively complete and recent surveillance data. Our study supports results of other studies by demonstrating independent associations of male circumcision with reduced cervical cancer rates and HIV cases, after stratifying the countries for Muslim and Christian religions, among a large sample of developing countries.
Others have described biologically plausible mechanisms by which male circumcision may reduce the transmission of certain STIs [18, 19, 44, 45]. First, circumcised males may have less difficulty maintaining penile hygiene, which may reduce the acquisition of STIs by decreasing inflammation and the carriage time of pathogens in the foreskin [19, 45]. Secondly, the non-keratinized epidermis of the prepuce in uncircumcised males may provide an easier portal of entry to STIs [19, 44, 45]. Third, the inner mucosal surface of the prepuce, which has a high density of HIV target cells (CD4+ T-cells, Langerhans cells, macrophages), has been shown to become more easily infected with HIV as compared to outer foreskin tissue [45]. Given these biological differences, it is entirely plausible that uncircumcised males are at a greater risk of acquiring some STIs, and of transmitting them to their sexual partners [12].
According to UNAIDS, heterosexual transmission was the primary mode of HIV transmission in Africa, the Middle East, the Caribbean, and South and South-East Asia, and homosexual transmission was the primary mode of HIV transmission in Latin America [37]. In our analysis, male circumcision was strongly associated with HIV among developing countries with heterosexual contact as the primary mode of HIV transmission, and not among developing countries whose primary mode of HIV transmission was not heterosexual contact (Eastern Europe, Central and Eastern Asia, Latin America, and the Pacific). These results further support the biological role of male circumcision as a protective factor in HIV transmission. Furthermore, the fact that HIV prevalence in many predominantly Christian countries that practice male circumcision, such as the Philippines, Benin, Ghana, Equatorial Guinea, and Gabon, is similarly low as in predominantly Muslim countries in the same regions, suggests that the biological effect of male circumcision may be at least as important as religion in determining HIV prevalence [24].

Conclusion

This study demonstrates that male circumcision was strongly associated with lower cervical cancer rates and fewer HIV cases among countries with heterosexual contact as the primary mode of HIV transmission, independent of religion. One randomized controlled trial has demonstrated that male circumcision is highly protective of HIV acquisition [21]. Therefore, while HIV and cervical cancer are impacted by a complex set of biological, social, and public health influences, male circumcision appears to play a prominent role in decreasing transmission of certain STIs. Although male circumcision must not substitute for other HIV and STI prevention strategies [46], the international public health and medical community should consider the implications and practicalities of integrating safe, voluntary male circumcision services with existing HIV prevention programs, particularly in countries with low prevalence of male circumcision and high prevalence of sexually-transmitted HIV.

Acknowledgements

Supported by the University of Washington Center for AIDS Research Grant AI 27757 and University of Washington STD Cooperative Research Center Grant AI 31448. The National Institutes of Health had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. The authors wish to thank David Wilson, Antonio de Moya and Jeff Marck for reviewing classification of countries by male circumcision prevalence, King Holmes and Beth Weaver-Green for reviewing drafts of the manuscript, and Mary Fielder and Ron Nelson for assistance with manuscript preparations.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

PKD, DTH, JPH, and RCB designed the study. PKD, DTH, and RCB collected and analyzed data. PKD, DTH, JPH, JDK, and RCB interpreted the results. PKD primarily wrote the manuscript. DTH, JPH, JDK, and RCB provided valuable insight for revising the manuscript. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
2.
Zurück zum Zitat Carael M, Buvé A, Awusabo-Asare K: The making of HIV epidemics: What are the driving forces?. AIDS. 1997, 2 (Suppl): 185-205. Carael M, Buvé A, Awusabo-Asare K: The making of HIV epidemics: What are the driving forces?. AIDS. 1997, 2 (Suppl): 185-205.
3.
Zurück zum Zitat Auvert B, Buvé A, Ferry B, Carael M, Morison L, Lagarde E, Robinson NJ, Kahindo M, Chege J, Rutenberg N, Musonda R, Laourou M, Akam E, Study Group on the Heterogeneity of HIV Epidemics in African Cities: Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS. 2001, 15 (Suppl 4): S15-S30. 10.1097/00002030-200108004-00003.CrossRefPubMed Auvert B, Buvé A, Ferry B, Carael M, Morison L, Lagarde E, Robinson NJ, Kahindo M, Chege J, Rutenberg N, Musonda R, Laourou M, Akam E, Study Group on the Heterogeneity of HIV Epidemics in African Cities: Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS. 2001, 15 (Suppl 4): S15-S30. 10.1097/00002030-200108004-00003.CrossRefPubMed
4.
Zurück zum Zitat Auvert B, Ferry B: Modeling the spread of HIV infection in four cities of sub-Saharan Africa [abstract]. Presented at XIV International AIDS Conference, 2002; Barcelona Auvert B, Ferry B: Modeling the spread of HIV infection in four cities of sub-Saharan Africa [abstract]. Presented at XIV International AIDS Conference, 2002; Barcelona
5.
Zurück zum Zitat Drain PK, Smith JS, Hughes JP, Halperin DT, Holmes KK: Correlates of national HIV seroprevalence. An ecological analysis of 122 developing countries. J Acquir Immune Defic Syndr. 2004, 35: 407-420.CrossRefPubMed Drain PK, Smith JS, Hughes JP, Halperin DT, Holmes KK: Correlates of national HIV seroprevalence. An ecological analysis of 122 developing countries. J Acquir Immune Defic Syndr. 2004, 35: 407-420.CrossRefPubMed
6.
Zurück zum Zitat Bongaarts J, Reining P, Way P, Conant F: The relationship between male circumcision and HIV infection in African populations. AIDS. 1989, 3: 373-377. 10.1097/00002030-198906000-00006.CrossRefPubMed Bongaarts J, Reining P, Way P, Conant F: The relationship between male circumcision and HIV infection in African populations. AIDS. 1989, 3: 373-377. 10.1097/00002030-198906000-00006.CrossRefPubMed
7.
Zurück zum Zitat Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, Cheang M, Ndinya-Achola JO, Piot P, Brunham RC: Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 1989, 2: 403-407. 10.1016/S0140-6736(89)90589-8.CrossRefPubMed Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, Cheang M, Ndinya-Achola JO, Piot P, Brunham RC: Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 1989, 2: 403-407. 10.1016/S0140-6736(89)90589-8.CrossRefPubMed
8.
Zurück zum Zitat Moses S, Bradley J, Nagelkerke N, Ronald AR, Ndinya-Achola JP, Plummer FA: Geographical patterns of male circumcision practices in Africa: association with HIV prevalence. Int J Epidem. 1990, 19: 693-697.CrossRef Moses S, Bradley J, Nagelkerke N, Ronald AR, Ndinya-Achola JP, Plummer FA: Geographical patterns of male circumcision practices in Africa: association with HIV prevalence. Int J Epidem. 1990, 19: 693-697.CrossRef
9.
Zurück zum Zitat Gray PB: HIV and Islam: is HIV prevalence lower among Muslims?. Soc Sci & Med. 2004, 58: 1751-1756. 10.1016/S0277-9536(03)00367-8.CrossRef Gray PB: HIV and Islam: is HIV prevalence lower among Muslims?. Soc Sci & Med. 2004, 58: 1751-1756. 10.1016/S0277-9536(03)00367-8.CrossRef
10.
Zurück zum Zitat Halperin DT, Bailey RC: Male circumcision and HIV infection: 10 years and counting. Lancet. 1999, 354: 1813-1815. 10.1016/S0140-6736(99)03421-2.CrossRefPubMed Halperin DT, Bailey RC: Male circumcision and HIV infection: 10 years and counting. Lancet. 1999, 354: 1813-1815. 10.1016/S0140-6736(99)03421-2.CrossRefPubMed
11.
Zurück zum Zitat Lavreys L, Rakwar JP, Thompson ML, Jackson DJ, Mandaliya K, Chohan BH, Bwayo JJ, Ndinya-Achola JO, Kreiss JK: Effect of circumcision on incidence of HIV and other STDs: a prospective cohort study of truck company employees in Kenya. J Infect Dis. 1999, 180: 330-336. 10.1086/314884.CrossRefPubMed Lavreys L, Rakwar JP, Thompson ML, Jackson DJ, Mandaliya K, Chohan BH, Bwayo JJ, Ndinya-Achola JO, Kreiss JK: Effect of circumcision on incidence of HIV and other STDs: a prospective cohort study of truck company employees in Kenya. J Infect Dis. 1999, 180: 330-336. 10.1086/314884.CrossRefPubMed
12.
Zurück zum Zitat Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, Mangen FW, Lutalo T, Nalugoda F, Kelly R, Meehan M, Chen MZ, Li C, Wawer MJ, for the Rakai Project Team: Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS. 2000, 14: 2371-2381. 10.1097/00002030-200010200-00019.CrossRefPubMed Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, Mangen FW, Lutalo T, Nalugoda F, Kelly R, Meehan M, Chen MZ, Li C, Wawer MJ, for the Rakai Project Team: Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS. 2000, 14: 2371-2381. 10.1097/00002030-200010200-00019.CrossRefPubMed
13.
Zurück zum Zitat Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, Franceschi S, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Male circumcision, penile Human Papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002, 346: 1105-1112. 10.1056/NEJMoa011688.CrossRefPubMed Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, Franceschi S, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Male circumcision, penile Human Papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002, 346: 1105-1112. 10.1056/NEJMoa011688.CrossRefPubMed
14.
Zurück zum Zitat Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR: Condom use and other factors affecting penile Human Papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Trans Dis. 2004, 31: 601-607. 10.1097/01.olq.0000140012.02703.10.CrossRef Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR: Condom use and other factors affecting penile Human Papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Trans Dis. 2004, 31: 601-607. 10.1097/01.olq.0000140012.02703.10.CrossRef
15.
Zurück zum Zitat Reynolds SJ, Shepherd ME, Risbud AR, Gangakhedkar RR, Brookmeyer RS, Divekar AD, Mehendale SM, Bollinger RC: Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet. 2004, 363: 1039-1040. 10.1016/S0140-6736(04)15840-6.CrossRefPubMed Reynolds SJ, Shepherd ME, Risbud AR, Gangakhedkar RR, Brookmeyer RS, Divekar AD, Mehendale SM, Bollinger RC: Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet. 2004, 363: 1039-1040. 10.1016/S0140-6736(04)15840-6.CrossRefPubMed
16.
Zurück zum Zitat Siegfried N, Muller M, Volmink J, Deeks J, Egger M, Low N, Weiss H, Walker S, Williamson P: Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2003, 3: CD003362-PubMed Siegfried N, Muller M, Volmink J, Deeks J, Egger M, Low N, Weiss H, Walker S, Williamson P: Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2003, 3: CD003362-PubMed
17.
Zurück zum Zitat Weiss HA, Quigley MA, Hayes RJ: Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000, 14: 2361-2370. 10.1097/00002030-200010200-00018.CrossRefPubMed Weiss HA, Quigley MA, Hayes RJ: Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000, 14: 2361-2370. 10.1097/00002030-200010200-00018.CrossRefPubMed
18.
Zurück zum Zitat Moses S, Plummer FA, Bradley JE, Ndinya-Achola JO, Nagelkerke NJ, Ronald AR: The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Trans Dis. 1994, 21: 201-210. 10.1097/00007435-199407000-00004.CrossRef Moses S, Plummer FA, Bradley JE, Ndinya-Achola JO, Nagelkerke NJ, Ronald AR: The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Trans Dis. 1994, 21: 201-210. 10.1097/00007435-199407000-00004.CrossRef
19.
Zurück zum Zitat Bailey RC, Plummer FA, Moses S: Male circumcision and HIV prevention: current knowledge and future research directions. Lancet Infect Dis. 2001, 1: 223-231. 10.1016/S1473-3099(01)00117-7.CrossRefPubMed Bailey RC, Plummer FA, Moses S: Male circumcision and HIV prevention: current knowledge and future research directions. Lancet Infect Dis. 2001, 1: 223-231. 10.1016/S1473-3099(01)00117-7.CrossRefPubMed
20.
Zurück zum Zitat Carael M, Cleland J, Deheneffe JC, Ferry B, Ingham R: Sexual behaviour in developing countries: implications for HIV control. AIDS. 1995, 9: 1171-1175.CrossRefPubMed Carael M, Cleland J, Deheneffe JC, Ferry B, Ingham R: Sexual behaviour in developing countries: implications for HIV control. AIDS. 1995, 9: 1171-1175.CrossRefPubMed
21.
Zurück zum Zitat Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Med. 29: e298- Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Med. 29: e298-
22.
Zurück zum Zitat Drain PK, Holmes KK, Hughes JP, Koutsky LA: Determinants of cervical cancer rates in developing countries. Int J Cancer. 2002, 100: 199-205. 10.1002/ijc.10453.CrossRefPubMed Drain PK, Holmes KK, Hughes JP, Koutsky LA: Determinants of cervical cancer rates in developing countries. Int J Cancer. 2002, 100: 199-205. 10.1002/ijc.10453.CrossRefPubMed
23.
Zurück zum Zitat United Nations Development Programme: Human Development Report 2004. 2004, New York: Oxford University Press United Nations Development Programme: Human Development Report 2004. 2004, New York: Oxford University Press
24.
Zurück zum Zitat Joint United Nations Programme on HIV/AIDS: Report on the Global HIV/AIDS Epidemic 2004. 2004, Geneva: UNAIDS Joint United Nations Programme on HIV/AIDS: Report on the Global HIV/AIDS Epidemic 2004. 2004, Geneva: UNAIDS
25.
Zurück zum Zitat Smith JS, Robinson J: Herpes simplex virus infections: a review of seroprevalence worldwide. J Infect Dis. 2002, 186 (Suppl 1): S3-28. 10.1086/343739.CrossRefPubMed Smith JS, Robinson J: Herpes simplex virus infections: a review of seroprevalence worldwide. J Infect Dis. 2002, 186 (Suppl 1): S3-28. 10.1086/343739.CrossRefPubMed
26.
Zurück zum Zitat Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2000: Cancer Incidence, Mortality, and Prevalence Worldwide, Version 1.0. 2001, International Agency for Research on Cancer CancerBase No. 5 Lyon, IARCPress, [http://www-dep.iarc.fr] Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2000: Cancer Incidence, Mortality, and Prevalence Worldwide, Version 1.0. 2001, International Agency for Research on Cancer CancerBase No. 5 Lyon, IARCPress, [http://​www-dep.​iarc.​fr]
27.
Zurück zum Zitat George Schmid, World Health Organization: Personal communication on June 4. 2004 George Schmid, World Health Organization: Personal communication on June 4. 2004
28.
Zurück zum Zitat World Health Organization: Hepatitis C – Global Prevalence (update). Weekly Epidemiol Rec. 1999, 49: 425-427. World Health Organization: Hepatitis C – Global Prevalence (update). Weekly Epidemiol Rec. 1999, 49: 425-427.
29.
Zurück zum Zitat Bailey RC, Neema S, Othieno R: Sexual behaviors and other HIV risk factors in circumcised and uncircumcised men in Uganda. J Acquir Immune Defic Syndr. 1999, 22: 294-301.CrossRefPubMed Bailey RC, Neema S, Othieno R: Sexual behaviors and other HIV risk factors in circumcised and uncircumcised men in Uganda. J Acquir Immune Defic Syndr. 1999, 22: 294-301.CrossRefPubMed
30.
Zurück zum Zitat Kebaabetswe P, Lockman S, Mogwe S, Mandevu R, Thior I, Essex M, Shapiro RL: Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect. 2003, 79: 214-219. 10.1136/sti.79.3.214.CrossRefPubMedPubMedCentral Kebaabetswe P, Lockman S, Mogwe S, Mandevu R, Thior I, Essex M, Shapiro RL: Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect. 2003, 79: 214-219. 10.1136/sti.79.3.214.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Addis Ababa University, Family Health International: Behavioral Surveillance Survey (BSS), Ethiopia 2002. 2003, Addis Ababa, Ethiopia: Addis Ababa University, Family Health International Addis Ababa University, Family Health International: Behavioral Surveillance Survey (BSS), Ethiopia 2002. 2003, Addis Ababa, Ethiopia: Addis Ababa University, Family Health International
33.
Zurück zum Zitat World Health Organization/Global Program on AIDS: 1989 Uganda Survey. 1989, Geneva: World Health Organization World Health Organization/Global Program on AIDS: 1989 Uganda Survey. 1989, Geneva: World Health Organization
36.
Zurück zum Zitat United Nations Population Division: World Population Prospects: The 2000 Revision. 2001, New York: United Nations United Nations Population Division: World Population Prospects: The 2000 Revision. 2001, New York: United Nations
37.
Zurück zum Zitat Joint United Nations Programme on HIV/AIDS: HIV/AIDS Epidemic Update 2002. 2002, Geneva: UNAIDS Joint United Nations Programme on HIV/AIDS: HIV/AIDS Epidemic Update 2002. 2002, Geneva: UNAIDS
39.
Zurück zum Zitat StataCorp: Stata Statistical Software: Release 8.0. 2004, College Station, Texas: Stata Corporation StataCorp: Stata Statistical Software: Release 8.0. 2004, College Station, Texas: Stata Corporation
40.
Zurück zum Zitat Caldwell JC, Caldwell P, Orubuloye IO: The family and sexual networking in sub-Saharan Africa: historical regional differentials and present-day implications. Population Studies. 1992, 46: 385-410. 10.1080/0032472031000146416.CrossRef Caldwell JC, Caldwell P, Orubuloye IO: The family and sexual networking in sub-Saharan Africa: historical regional differentials and present-day implications. Population Studies. 1992, 46: 385-410. 10.1080/0032472031000146416.CrossRef
41.
Zurück zum Zitat Carael M: Sexual behaviour. Sexual Behaviour and AIDS in the Developing World. Edited by: Cleland J and Ferry B. 1995, London: Taylor & Francis, 75-123. Carael M: Sexual behaviour. Sexual Behaviour and AIDS in the Developing World. Edited by: Cleland J and Ferry B. 1995, London: Taylor & Francis, 75-123.
42.
Zurück zum Zitat Halperin DT, Epstein H: Concurrent sexual partnerships help to explain Africa's high HIV prevalence: implications for prevention. Lancet. 2004, 363: 4-6. 10.1016/S0140-6736(04)16606-3.CrossRef Halperin DT, Epstein H: Concurrent sexual partnerships help to explain Africa's high HIV prevalence: implications for prevention. Lancet. 2004, 363: 4-6. 10.1016/S0140-6736(04)16606-3.CrossRef
43.
Zurück zum Zitat Weiss HA, Thomas SL, Munabi SK, Hayes RJ: Male circumcision and risk of syphilis, chancroid and genital herpes: a systematic review and meta-analysis. STI Online. 2006, 82: 101-110. Weiss HA, Thomas SL, Munabi SK, Hayes RJ: Male circumcision and risk of syphilis, chancroid and genital herpes: a systematic review and meta-analysis. STI Online. 2006, 82: 101-110.
45.
Zurück zum Zitat Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, Chaviano A, Bailey RC: Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Amer J Pathology. 2002, 16: 867-873.CrossRef Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, Chaviano A, Bailey RC: Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Amer J Pathology. 2002, 16: 867-873.CrossRef
46.
Zurück zum Zitat Halperin DT, Steiner MJ, Cassell MM, Green EC, Hearst N, Kirby D, Gayle HD, Cates W: The time has come for common ground on preventing sexual transmission of HIV. Lancet. 2004, 364: 1913-1915. 10.1016/S0140-6736(04)17487-4.CrossRefPubMed Halperin DT, Steiner MJ, Cassell MM, Green EC, Hearst N, Kirby D, Gayle HD, Cates W: The time has come for common ground on preventing sexual transmission of HIV. Lancet. 2004, 364: 1913-1915. 10.1016/S0140-6736(04)17487-4.CrossRefPubMed
Metadaten
Titel
Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries
verfasst von
Paul K Drain
Daniel T Halperin
James P Hughes
Jeffrey D Klausner
Robert C Bailey
Publikationsdatum
01.12.2006
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2006
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-6-172

Weitere Artikel der Ausgabe 1/2006

BMC Infectious Diseases 1/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.